The inflammatory response to colloids and crystalloids used for pump priming during cardiopulmonary bypass.
BACKGROUND
Systemic inflammatory response frequently occurs after coronary artery bypass surgery and is strongly correlated with the risk of postoperative morbidity and mortality. This study tests the hypothesis that the priming of the extracorporeal circuit with colloid solutions results in less inflammation in patients undergoing cardiac surgery than priming with crystalloid solutions.


METHODS
A prospective, randomized study was designed. Forty-four patients undergoing elective coronary artery bypass grafting were randomly allocated to one of two groups: 22 patients primed with Ringer's lactate (RL) solution and 22 patients primed with gelatin-containing solution during the surgery. Plasma levels of interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-alpha, C-reactive protein (CRP) and, complement 4 were measured during the surgical intervention and over the following 48 postoperative hours. Cytokine levels were measured by enzyme-linked assays from plasma samples obtained at specific time points pre- and post-operatively.


RESULTS
In both groups the serum levels of the pro-inflammatory cytokines (IL-6, IL-8, TNF-alpha), CRP, complement 4, and leukocytes increased significantly over the baseline, although no significant differences were observed between the two groups. The operation time, blood loss, need for inotropic support, extubation time, and length of intensive care unit stay did not differ significantly between the two groups.


CONCLUSIONS
Priming with gelatin vs. RL produces no significant differences in the inflammatory response in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
Tamayo
E
E
Department of Anaesthesiology and Reanimation, Valladolid University Hospital, Valladolid, Spain. tamayo@med.uva.es
Alvarez
F J
FJ
Alonso
O
O
Castrodeza
J
J
Bustamante
R
R
Gómez-Herreras
J I
JI
Florez
S
S
Rodríguez
R
R
D000368:Aged; D002097:C-Reactive Protein / Q000378:metabolism; D002315:Cardiopulmonary Bypass / Q000379:methods*; D002318:Cardiovascular Diseases / Q000097:blood / Q000503:physiopathology / Q000601:surgery*; D003102:Colloids; D003181:Complement C4 / Q000378:metabolism; D000077324:Crystalloid Solutions; D016207:Cytokines / Q000097:blood; D005260:Female; D005780:Gelatin / Q000009:adverse effects*; D006353:Heart-Assist Devices; D006439:Hemodynamics; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000139:chemically induced / Q000473:pathology; D007552:Isotonic Solutions / Q000494:pharmacology*; D019344:Lactic Acid / Q000009:adverse effects*; D008297:Male
D003102:Colloids; D003181:Complement C4; D000077324:Crystalloid Solutions; D016207:Cytokines; D007552:Isotonic Solutions; D019344:Lactic Acid; D005780:Gelatin; D002097:C-Reactive Protein